AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 66 min read$SUNS

Sunrise Realty Trust, Inc. (SUNS): Results of Operations and Financial Condition

Sunrise Realty Trust, Inc. (SUNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sunsearningsreleaseq22026e.htm EX-99.1 Document Sunrise Realty Trust, Inc. Announces Financial Results for the Second Quarter 2026 Second quarter 2026 GAAP net income of $3.1 million or $0.23 per basic weighted average common share and Distributable Earnings ( 1 ) of $3

Original reporting
SEC EDGAR 8-K
Published Aug 6, 2026, 11:35 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 12:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$SUNS
Bullish
medium confidence
Mentioned
$SUNS
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SUNSBullishMed
01

Why it matters

Traders can reassess near-term expectations for dividend coverage and credit risk based on reported distributable earnings, dividend declared/paid, and the stated status of loan performance plus a specific repayment event after quarter end.

02

Market read

Primary earnings disclosure with concrete figures and dividend coverage, plus qualitative credit and liquidity signals that can move short-term positioning.

03

What to watch

Investors may focus on CECL/provisioning trajectory and the sustainability of distributable earnings versus GAAP net income, which can diverge in mortgage/CRE lenders.

Relevance 7/10Novelty 7/10Timing: filed pre-market today, with an investor call scheduled for 10:00 a.m. ET today

Background

The 8-K (Item 2.02) reports Sunrise Realty Trust’s Q2 2026 results and includes a dividend update and management commentary on portfolio performance and liquidity.

Company-level read

Ticker impact

$SUNSBullishMedium confidence
Context

Sunrise Realty Trust reported Q2 2026 GAAP net income of $3.1M and Distributable Earnings of $3.9M, plus a $0.30 dividend.

Expected impact

Moderate positive bias for the next session and into the earnings-call window, assuming investors view distributable earnings coverage and loan performance as stable.

Evidence & confidence

The filing is a primary earnings release (8-K with results) including specific income, distributable earnings, dividend amount, and qualitative credit/liquidity statements (loans current, repayment of Panther National).

Market effects

Sector

Adds datapoint on CRE lending performance and dividend sustainability for transitional CRE lenders amid elevated rates.

Regional

Highlights Southern U.S. CRE exposure and lender liquidity management in that geography.

Global

Limited direct global spillover; primarily a U.S. CRE credit and REIT income story.

Counterpoint

What could challenge this read

Distributable Earnings is non-GAAP, and the release provides limited detail on credit quality trends beyond 'all loans remain current,' so downside risk may be underappreciated.

Key entities

  • company
    Sunrise Realty Trust, Inc.

    Nasdaq-listed CRE lender reporting Q2 2026 GAAP net income, Distributable Earnings, and a $0.30 quarterly dividend.

  • counterparty
    Panther National

    Investment that was fully repaid shortly after quarter end, cited as reinforcing liquidity and exit capability.

  • platform
    Tannenbaum Capital Group (TCG) Real Estate platform

    Described as the platform where SUNS originates and structures transitional CRE financing.

Read at source← All news

Related articles

AUG 13
$LLYMedAI 8/10

Lilly Highlights Sleep Apnea Drug Progress and Sleep-Wake Disorder Acquisition in Q2 Report

Eli Lilly reported Q2 2026 results, saying worldwide revenue rose 48% to $23.0B, driven by volume growth led by Mounjaro and Zepbound, and raised full-year revenue guidance to $85B-$87B. In pipeline updates, the company said its triple agonist retatrutide improved obstructive sleep apnea in trials. Lilly also completed its acquisition of Centessa Pharmaceuticals to advance sleep-wake disorder treatments.

sleepreviewmag.com4 min
AUG 13
$QTIMedAI 8/10

QT Imaging (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings (QTI) reported Q2 2026 revenue of $7.4 million, up 103% year over year, driven by 15 scanner shipments. First-half revenue was $14 million. Fiscal 2026 guidance calls for about $39 million revenue. Q2 gross margin was 41%; operating loss $1.9 million and net loss $11.1 million. Company extended debt to 2029 and raised $10 million via an offering.

fool.com7 min
AUG 13
$FENCMed

Adherex Technologies Q2 Earnings Call Highlights

Fennec Pharmaceuticals (NASDAQ:FENC) reported Q2 results on an earnings call. Net product sales were $17.1 million, up 78% year over year. Non-GAAP adjusted EBITDA was $2.8 million versus a $1.2 million loss a year earlier. Cash and cash equivalents were $41.2 million at June 30, 2026. Management cited PEDMARK momentum and no quantitative 2026 revenue outlook.

yahoo.com6 min
AUG 13
$MIDDMedAI 8/10

Middleby Q2 Earnings Call Highlights

Middleby (NASDAQ:MIDD) said dealer-channel growth remains positive but should moderate in H2, with Q3 and Q4 growth driven mainly by chain customers. Q2 organic adjusted EBITDA margin was 25.8%, below expectations due to mix, inflation and ice and beverage investments. Q2 adjusted EBITDA was ~$193M and adjusted EPS $2.35. Full-year organic growth outlook raised to 6% to 8%.

yahoo.com6 min
AUG 13
$HROWMed

Harrow Q2 Earnings Call Highlights

Harrow (NASDAQ:HROW) reported Q2 revenue of $15.6M for IHEEZO, with demand up to 65,477 units (+44% sequential, +34% YoY) but revenue lagging due to distributor sell-through of prior inventory. Management cited normalized channel inventory, ~25% higher net pricing effective July 1, gross margin 71%, and cash of $83.9M. Harrow also discussed BYOOVIZ launch, VEVYE PBM coverage, and a pending TYRVAYA acquisition.

yahoo.com6 min